Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
103
days
Internalization-Dependent EGFR-Targeted Photoactivation by Cetuximab-I21 Conjugates
Authors
Wentao Shang; Hua Shang; Josie Cai; Qin Vicky; Lyan Chen; Huiqiang Wang; Xiaobo ZhangShow moreShow less
Affiliations
1. Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China; 2. Shanghai Biophy Biological Pharmaceutical Co, Ltd, Shanghai, ChinaShow moreShow less
298
days
Integrated Analysis of Single-cell and Bulk RNA-Sequencing Identifies a Signature Based on Cancer-related Fibroblast Marker Genes to Predict Prognosis and Therapy Response in Lung Adenocarcinoma
Authors
Gengqiu Liu; Jiacheng Feng; Yufeng Huang; Junhang Zhang; Yong LiShow moreShow less
Affiliations
1. Department of Thoracic Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China; 2. The Pharmacy College of Jiangxi Science and Technology Normal University. Jiangxi, Nanchang, China; 3. Department of Thoracic Surgery, BaoAn Central Hospital of Shenzhen, Shenzhen, ChinaShow moreShow less
121
days
Brief Communication on MAGE-A4 and Coexpression of Cancer Testis Antigens in Metastatic Synovial Sarcomas: Considerations for Development of Immunotherapeutics
Authors
Hélène Vanacker; Robert Connacher; Alexandra Meurgey; Julien Bollard; Valéry Attignon; Franck Tirode; Myriam Jean-Denis; Mehdi Brahmi; Jean-Yves Blay; Ruoxi Wang; Dennis Williams; Armelle DufresneShow moreShow less
Affiliations
1. Centre Léon-Bérard, Lyon, France; 2. Adaptimmune, Philadelphia, PA; 3. Adaptimmune, Abingdon, Oxfordshire, UKShow moreShow less
185
days
Mucin-1–Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host
Authors
Ru Zhou; Shu-ta Wu; Mahboubeh Yazdanifar; Chandra Williams; Alexa Sanders; Cory Brouwer; John Maher; Pinku MukherjeeShow moreShow less
Affiliations
1. Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC; 2. Medpace, Irving, TX; 3. Adaptive Biotechnologies, South San Francisco, CA; 4. Pfizer, Cambridge, MA; 5. Department of Bioinformatics, University of North Carolina at Charlotte, Charlotte, NC; 6. King’s College London, School of Cancer and Pharmaceutical Sciences, Guy’s Cancer Centre, London, UKShow moreShow less
77
days
Clinical Outcomes of PD-1/PD-L1 Inhibitors Among Patients With Advanced or Metastatic Non–Small Cell Lung Cancer With BRAF, ERBB2/HER2, MET, or RET Alterations: A Systematic Literature Review
Authors
Katherine G. Akers; Sabine Oskar; Bin Zhao; Andrew M. Frederickson; Ashwini ArunachalamShow moreShow less
Affiliations
1. PRECISIONheor, New York, NY; 2. Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days